title: Intense migraines secondary to percutaneous closure of atrial septal defects.
abstract: In this study we evaluated the development of migraine after percutaneous closure of atrial septal defect. An abrupt and excruciating form of migraine developed shortly after shunt closure in 5 of 13 consecutive patients undergoing this procedure. A dramatic relief of pain was achieved almost instantaneously after administration of 300 mg of clopidogrel.
authors.affiliation: Section of Cardiology, Department of Medicine, Texas Tech University Health Sciences, Center, Odessa, Texas, USA. seyedmohsensharifi@yahoo.com
authors.forename: Mohsen
authors.initials: M
authors.lastname: Sharifi
authors.forename: Majid
authors.initials: M
authors.lastname: Dehghani
authors.forename: Mahshid
authors.initials: M
authors.lastname: Mehdipour
authors.forename: Omar
authors.initials: O
authors.lastname: Al-Bustami
authors.forename: Farnaz
authors.initials: F
authors.lastname: Emrani
authors.forename: James
authors.initials: J
authors.lastname: Burks
mesh_terms: D000328:Adult; D006328:Cardiac Catheterization; D000077144:Clopidogrel; D017548:Echocardiography, Transesophageal; D005260:Female; D005500:Follow-Up Studies; D006344:Heart Septal Defects, Atrial / Q000000981:diagnostic imaging / Q000601:surgery*; D006801:Humans; D008297:Male; D020326:Migraine without Aura / Q000188:drug therapy / Q000209:etiology*; D019060:Minimally Invasive Surgical Procedures / Q000009:adverse effects*; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011183:Postoperative Complications; D012720:Severity of Illness Index; D013988:Ticlopidine / Q000031:analogs & derivatives / Q000627:therapeutic use; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D010975:Platelet Aggregation Inhibitors; D000077144:Clopidogrel; D013988:Ticlopidine